Robert P. Wise
- Infectious Diseases top 0.5%
- Epidemiology top 1%
- Influenza Virus Research Studies 5
- Herpesvirus Infections and Treatments 4
- Rheumatology top 1%
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions 4
- Health top 2%
- Vaccine Coverage and Hesitancy 5
-
- Heparin-Induced Thrombocytopenia and Thrombosis 7
-
- Drug-Induced Adverse Reactions 4
-
- Blood groups and transfusion 4
-
- Pharmaceutical studies and practices 3
- Co-authors
- M. Miles BraunWilliam D. SchwietermanSharon K. GershonJeffrey SiegelJoseph KeaneJohn KasznicaRobert BallCraig Zinderman
- Partner nations
- United StatesSwitzerlandSweden
In The Last Decade
Robert P. Wise
42 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Infectious Diseases 1.8k
- Epidemiology 2.1k
- Rheumatology 824
- Toxicology 178
- Health 419
Countries citing papers authored by Robert P. Wise
This map shows the geographic impact of Robert P. Wise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. Wise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. Wise more than expected).
Fields of papers citing papers by Robert P. Wise
This network shows the impact of papers produced by Robert P. Wise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. Wise. The network helps show where Robert P. Wise may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert P. Wise, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 1 | |
| 2 | 2017 | 1 | |
| 3 | 2017 | 1 | |
| 4 | 2016 | 8 | |
| 5 | 2013 | 3 | |
| 6 | 2010 | 21 | |
| 7 | 2008 | 79 | |
| 8 | 2007 | 22 | |
| 9 | 2007 | 89 | |
| 10 | 2007 | 45 | |
| 11 | 2007 | 21 | |
| 12 | 2006 | 77 | |
| 13 | 2005 | 15 | |
| 14 | Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agentbreakdown → | 2001 | 2706 |
| 15 | 2001 | 26 | |
| 16 | 2001 | 53 | |
| 17 | 2000 | 156 | |
| 18 | 1998 | 4 | |
| 19 | 1997 | 281 | |
| 20 | 1990 | 18 |
About Robert P. Wise
Robert P. Wise is a scholar working on Toxicology, Transplantation, Health, Neuropsychology and Physiological Psychology and Microbiology, having authored 44 papers that have together received 4.9k indexed citations. Recurring topics across this work include Heparin-Induced Thrombocytopenia and Thrombosis (7 papers), Influenza Virus Research Studies (5 papers), Vaccine Coverage and Hesitancy (5 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers), Drug-Induced Adverse Reactions (4 papers), Herpesvirus Infections and Treatments (4 papers), Blood groups and transfusion (4 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Epidemiology (2.1k citations), Rheumatology (824 citations), Toxicology (178 citations) and Health (419 citations). Robert P. Wise has collaborated with scholars based in United States, Switzerland and Sweden. Frequent co-authors include M. Miles Braun, William D. Schwieterman, Sharon K. Gershon, Jeffrey Siegel, Joseph Keane, John Kasznica, Robert Ball, Craig Zinderman, Penina Haber and S Brown. Their work appears in journals such as Vaccine, JAMA, Pharmacoepidemiology and Drug Safety, The Pediatric Infectious Disease Journal and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.